is it time for biotechs?, page-7

marsbar $$revenue for Xceed is a while off, but obviously we are talking big numbers
Biotech investors like the intellectual propperty
Same outfit that helped float(and acquire the technology) behind Exceed is also the foundation to Avantogen..Roger Aston is still a director of ACU I believe( or head of scientific committee. I think he is the driver) .

ACU has had buying bursts over the past six months
Volume buying has occured on bs announcements which although positive have not been the reasons behind the buying...Prices between 15-18 for those big volume days...
Phase2 results for Pentrys coming v soon ...
If anyone is not sure of the monetary value of the company-should these phase2 results be positive- I suggest you go over some old posts.